As we age it becomes depleted resulting in fatigue, mental fog, lack of concentration, inflammation/oxidative stress, dull and tired looking skin, decreased endurance, and increased symptoms of chronic disease
For patients who need long-term treatment, the phentermine-topiramate combination (Qsymia) is FDA-approved for extended use and may be an appropriate next step
Facility implications of an oral solid dosage format for GLP-1s: Shifting from an injectable to an oral dosage form could dramatically streamline the GLP-1 manufacturing lifecycle
Provider assessment should consider both mechanism fit and individual metabolic markers
Recent advances in understanding the role of erythrocyte RCDs in health and disease have expanded potential clinical applications of these lethal subroutines, emphasizing their contribution to the development of anemia, microthrombosis, and endothelial dysfunction, as well as their role as diagnostic biomarkers and markers of erythrocyte storage-induced lesions